
Loetitia Jabri considers the broader implications as healthcare providers embraces new digital connectivity options as part of the Medicine 2.0 era.
Loetitia Jabri is regulatory, pharmaceutical & medical devices platforms associate director at ProductLife Group.

Published: February 21st 2019 | Updated: